Reviva Pharmaceuticals (RVPH) Q2 2025 Earnings

15MayConfirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-0.38
-0.29
-0.21
-0.13

Details

Expected EPS
-0.1971
Actual EPS
-0.13
Surprise EPS
0.07
Surprise Percent
+34.04%

Description

Reviva Pharmaceuticals (RVPH) has reported earnings of -0.13 per share for Q2 2025.

0 Comments

Share your thoughts